OcumatRx

OcumatRx

  • Company
  • The Leadership Team
  • Advanced Technology
  • CaPRI
  • Castillejos Onidesys
  • Product Development
  • News
  • Contact

Restoring Sight with the CaPRI Glaucoma Implant

OcumatRx has pioneered the development of a new medical device that represents the first permanent treatment for patients with Early Stage Glaucoma and Glaucoma. Implanted in an outpatient setting, this breakthrough device stabilizes intra-ocular pressure and stops the progression of Glaucoma in the early stages, before it begins advancing toward tunnel vision and eventual blindness.

"Experts believe the device will fundamentally
change the way Glaucoma is treated throughout the world..."


Ocumatrx-istock-collage-1

Contact Us





Disclaimer: The Food and Drug Administration has not evaluated any of the statements contained on this web site. The information contained on this site is not intended to diagnose, treat, cure or prevent any disease. There are no warranties, expressed or implied, as to accuracy, completeness, or results obtained from any information posted on this or any linked websites. This website is strictly for informational and purposes only and does not constitute a complete description of all or any one aspect of the business opportunity. There is no offer to invest, sell or buy any financial product on this website. Please consult with a qualified financial advisor before investing.

Site by Steve Dahl & Associates, Inc.